ANTIANXIETY PROPERTY OF BASELLA ALBA LINN LEAVES EXTRACT IN EXPERIMENTAL ANIMALS - BIBLIOGRAPHY

 

9. BIBLIOGRAPHY

1.            Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Arch Gen Psychiatry 2005; 62: 593–602.

2.            Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR. JClin Psychiatry 1990; 60: 427–435.

3.            Prevalence of Phobias in the United State.

Available from: http://www.phobias.about.com/od/prevalence/a/phobprevus

4.            Rang HP, Dale MM, Ritter JM, Moore PK. Pharmacology. 5th ed. Elsevier; 2006: p.535-543.

5.            Kunovac JL and Stahl SM. Future directions in anxiolytic pharmacotherapy. Psychiatry.  Clin. North Am 1995; 18: 895–909.

6.            Ernst E. Herbal remedies for anxiety – a systematic review of controlled clinical trials, Phytomedicine 2006; 13: 205–208.

7.            Goodman and Gilman's. The Pharmacological Basis of Therapeutics. The New York: McGraw-Hill; 1996. p. 399-557.

8.            Longo, LP, Johnson B. Addiction: Part I. Benzodiazepines: Side effects, abuse risk and alternatives. American Family Physician 2000; 61: 2121-2128.

9.            Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia are they justified. European Neuropsychopharmacology1999; 9 (Suppl6): S399-S404.

10.        Rickels K, Case WG, Downing RW, Winokur A. Long-term diazepam therapy and clinical outcome. Journal of American Medical Association 1983; 250: 767-771.

11.        Woods JH, Katz JL, Winger G. Abuse liabilities of benzodiazepines. Pharmacology Reviews 1987; 39: 251-413.

12.        Ashton H. Benzodiazepine withdrawal an unfinished story. British Medical Journal 1984; 288: 1135-40.

13.        Busto U, Sellers EM, Naranjo CA, Cappell HP, Sanchez CM, Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. New England Journal of Medicine 1986; 315: 654-59.

14. Lance P. Longo, Brian Johnson. Addiction: Part I  Benzodiazepines Side Effects, Abuse Risk and Alternatives. Am Fam Physician 2000 ; 61(7): 2121-2128.  

15.        Palva ES, Linnoila M, Saario I, Mattila M. Acute and subacute effects of diazepam on psychomotor skillsm, interactions with alcohol. Acta pharmacol Toxicol 1979; 45:257-264.)

16.        Importance of Medicinal plants, http;//www.ayuvedaherbs.wordpress.com

17.        Steve Blake. Medicinal Plant Actions. Excerpts from the full book: Medicinal Plants  Starting with C and D. URL: http://www.NaturalHealthWizards.com

18.        Inamdar Nazma, Esalat Shima, Kotwal VB, Pawar Sunita. Herbal drugs in milieu of modern drugs. International Journal of green pharmacy 2008; 2 (1): p.2-8.

19.        Larner and Brody. Brody’s Human Pharmacology. Molecular to Clinical. 4^th edition; 2005: p.305.

20.        Kamaldeep Dhawan, Suresh kumar and Anupam Sharma. Anti-anxiety studies on extracts of Pssiflora incarnate Linn. Journal of Ethnopharmacology 2001; 78(2-3): 165-170.

21.        The Merck Index. Monograph No-2278, 13^th edition, 391p.

22.        Sankara S, Subramanium, Nagarjan S, Sulochana N. Chrysin 7- rutinoside from the leaves of Dolichandrone falcata, Phytochemistry 1972; 2(1): 438-439.

23.        Suresh Babu K, Hari Babu T, Srinivas PV, Harakishor K, Murty USN, Madhusudanaa Rao J. Synthesis and biological evaluation of novel C(7) modified chrycin analogues as antibacterial agents.Bioorganic and medicinal chemistry latters 2006;16: 221-224.

24.        Kumar V. Potential Medicinal Plants for CNS Disorders: an Overview. Phytother. Res 2006; 20: 1023–1035.

25.        Anguirre-hernandez E, Gonzalez-trujano ME, Martinez AL, Moreno J, Kite G, Terrazas T, et al. HPLC/MS analysis and anxiolytic-like effect of quercetin and kaempferol flavonoids from Tilia Americana var. mexicana. Journal of ethanopharmacology 2010 Jan 8;127(1):91-97.

26.        Herrara-ruiz M, Roman-ramos R, Zamilpa A, Tortoriello J, Jimenez-ferrer JE. Flavonoids from Tilia Americana with anxiolytic activity in plus-maze test. Journal of ethanopharmacology  2008 Jul 23;118(2):312-317.

27.        De Almeida ER, Xavier HS, Chaves TM, Couto GBL, Aragao-Neto AC, Silva AR, et al. Anxiolytic and anticonvulsant effects of dioclenol flavonoid isolated from stem bark of dioclea grandiflora on mice. International journal of applied research in natural products 2009 Dec-2010 Jan;2(4):44-51.

28.        Coleta M, Batista MT, Campos MG, Carvalho R, Cotrim MD, M. de lima TC, et al. Neuropharmacological Evaluation of the putative anxiolytic effects of Passiflora edulis sims, its sub-fractions and flavonoid constituents. Phytotherapy research 2006 Sep 28;20:1067-1073.

29.        Wolfman C, Viola H, Dasjas F, Medina JH. Possible anxiolytic  effects of chrysin, a central benzodiazepine receptor ligand isolated from passiflora coerulea. Pharmacol biochem behave. 1994 Jan;47(1):1-4.

30.        Anandarajagopal K, Sudhahar D, Ajaykumar TV, Muthukumar G. Evaluation of CNS depressant activity of aerial parts of Basella alba Linn. IJPI’s Journal of Pharmacology and Toxicology 2011;1(5):1-6.

31.        Reshmi SK, Aravinthan KM, Suganyad devi P. Antioxidant analysis of betacycnin extracted from Basella alba fruit. International Journal of PharmaTech research 2012 jul-sep;4(3):900-913.

32.        Yang RY, lin S, kuo G. Content and distribution of flavonoids among 91 edible plant species. Asia Pac J Clin Nutr 2008;17(S1):275-279.

33.        Grundmann O, Nakajima J, Kamata K, Seo S, Butterweck V. Kampferol from the leaves of apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice. Phytomedicine 2009 Apr;16(4):295-302.

34.        Basella alba Linn. [online]. [cited on 2013 Feb 25]; Available from: http://en.wikipedia.org/wiki/Basella_alba.

35.        Mohapatra SP, Sahoo HP. An ethno-medico-botanical study of bolangir, Orissa, India: Native plant remedies against gynaecological diseases. Ethnobotanical leaflets 2008;12:846-850.

36.        Olowokudejo JD, Kadiri AB, Travih VA. An ethnobotanical survey of herbal markets and medicinal plants in lagos state of Nigeria. Ethnobotanical leaflets 2008;12:851-865.

37.        Titanji VPK, Zofou D, Ngemenya MS. The antimalarial potential of medicinal plants used for the treatment of malaria in Cameroonian folk medicine. Afr. J. Traditional, complementary and alternative medicines 2008;5(3):302-321.

38.        Bamidele O, Akinnuga AM, Olorunfemi JO, Odetola OA, Oparaji CK, Ezeigbo N. Effects of aqueous extract of Basella alba leaves on haematological and biochemical parameters in albino rats. African journal of biotechnology 2010 Oct 11;9(41):6952-6955.

39.        Kuete V, Efferth T. Cameroonian medicinal plants: pharmacology and derived natural products. Frontiers in Pharmacology 2010 Oct 25;1:123.

40.        Chaitanya KB. Anti inflammatory activity of Basella alba Linn. in albino rats. Journal of Applied Pharmaceutical Science 2012;2(4):87-89.

41.         Moundipa PF, Beboy NSB, Zelefack F, Ngouela S, Tsamo E, Schill WB, et al. Effects of Basella alba and Hibiscus macranthus extracts on testosterone production of adult rat and bull ley dig cells. Asian journal of andrology 2005 Dec;7(4):411-417.

42.        Kumar V, Bhat ZA, Kumar D, Khan NA, Chashoo IA, Ara I. Gastroprotective effect of leaf extracts of Basella alba var. alba against experimental gastric ulcers in rats. Brazilian Journal of Pharmacognosy  2012 May/Jun;22(3):657-662.

43.        Murray MT. Quercetin nature’s antihistamine. Better Nutrition 1998.

44.        Cook NC, Samman, S. Flavonoids Chemistry, metabolism, cardioprotective effects and dietary sources. Nutritional Biochemistry 1996; 7: 66-76.

45.        Williams RJ, Spencer JPE, Rice-Evans C. Serial review: Flavonoids and isoflavonones (Phytoestrogens) Absorption, Metabolism and Bioactivity. Free Radical Biology and Medicine 2004; 36: 838-849.

46.        Tsuchiya H. Structure-dependent membrane interaction of flavonoids associated with their bioactivity. Food Chemistry 2010; 120: 1089-1096.

47.        Chebil L, Humeau C, Falcimaigne A, Engasser J, Ghoul M. Enzymatic acylation of flavonoids. Process Biochemistry 2006; 41: 2237-2251.

48.        Middleton EJR, Kandaswami C, Theoharides TC. The Effects of Plant Flavonoids on Mammalian cells, implications for inflammation, heart disease, and cancer. Pharmacological Reviews 2000; 52: 673-751.

49.        Narayana KR, Reddy SR, Chaluvadi MR, Krishna DR. Bioflavonoid classification, pharmacological, biochemical effects and therapeutic potential. Indian Journal of Pharmacology 2001; 33: 2-16.

50.        Kumar P. INDIAN SPINACH, Basella alba (PUI) succulent, branched, smooth, twining herbaceous vine. Best Nutrition, 2010

51.        Yang RY, Lin S, Kuo G. Content and distribution of flavonoids among 91 edible plant species. Asia Pac J Clin Nutr. 2008; 17(S1): 275-279.

52.        Toshiyuki M, Kazuhiro H, Masayuki Y. Medicinal foodstuffs. XXIII. Structures of new oleananetype triterpene oligoglycosides, basellasaponins A, B, C, and D, from the fresh aerial parts of Basella rubra L. Chem Pharm Bull. 2001; 49:776-779.

53.        Khare CP. Indian medicinal plants: an illustrated dictionary. USA: Springer Science Business Media, 2007.

54.        Maisuthisakul P, Ritthiruangdej PS. Relationship between antioxidant properties and chemical composition of some Thai plants. J Food Compos Anal. 2008; 21:229-240.

55.        Glassgen WE, Metzger JW, Heuer S, Strack D. Betacyanins from fruits of Basella rubra. Phytochemistry 1993; 33:1525-1527.

56.        Palanuvej C, Hokputsa S, Tunsaringkarn T, Ruangrungsi N. In vitro glucose entrapment and alpha-glucosidase inhibition of mucilaginous substances from selected Thai medicinal plants. Sci Pharm. 2009; 77:837-849.

57.        Haq QN, Awal A, Chowdhury MK, Khan NA. Water-soluble polysaccharides from the leaves of Basella rubra. Sci Res. 1969; 6:63-6.

58.        Jani GK, Shah DP, Jain VC, Patel MJ, Vithalani DA. Evaluating mucilage from Aloe Barbadensis Miller as a pharmaceutical excipient for sustained release matrix tablets. Pharm Technol. 2007; 31:90-98.

59.        Olajire AA, Azeez L. Total antioxidant activity, phenolic, flavonoid and ascorbic acid contents of Nigerian vegetables, African Journal of Food Science and Technology 2011; 2(2): 022-029.

60.        Barbosa-Filho JM, Alencar AA, Nunes XP, Tomaz ACA, Sena-Filho JG, Athayde-Filho PF, Silva MS, Souza MFV, da-Cunha EVL. Sources of alpha-, beta-, gamma-, delta- and epsilon-carotenes: A twentieth century review, Brazilian Journal of Pharmacognosy 2008; 18(1): 135-154.

61.        Schmidt DR, MacDonald HA, Brockman FE. Oxalate and Nitrate Contents of Four Tropical Leafy Vegetables Grown at Two Soil Fertility Levels. Agronomy Journal 1970; 63(4): 559-561.

62.        Roshan Adhikari, Naveen Kumar HN, Shruthi SD. A Review on Medicinal Importance of Basella alba L. 2012;4(2):110-114.

63.        Basella alba Linn. [online].; Available from: http://mariekesjournal.blogspot.in/2010/04/mariekes-diary.html

64.        Karan Sharma, Narendra Kumar, Kirandeep Raj, Junaid Niazi, Vikas Gupa. Anti anxiety activity of Eriobotrya japonica leaf extracts. Research Journal of Pharmaceutical, Bilogical and Chemical Sciences 2011; 2(1):255-259.

65.        Habibur Rahman, A. Elumalai M. Chinna Eswaraiah and Dipankar Bardalai. Evaluation of anxiolytic activity of pisonia grandis R. Br leaves in mice. Journal of Chemical and Pharmaceutical Research 2011;3(5):646-652.

66.        Sathish Kumar, P. Amudha, C. Satheesh Kannan. Evaluation of anxiolytic activity of hydroalcoholic extract of teprosia purpuria (L) pers on swiss alwino mice. Internatinal Journal of Pharmaceutical Sciences Research 2011;2(5):1262-1269.

67.        Navdeep Singh, Sarabjit Kaur, Bedi PMS, Divneer kaur. Anxiolytic effect of Equisetum arvense Linn. Extracts in mice. Indian Journal of Experimental Biology 2011; 49:352-356.

68.        Sudhakar Pemminati, Gopalakrishna HN, Venkatesh.V, Amritha Raj, Sowjanya Shetty, Amrita Vinod, Bethi Yugandhar, Ashok K Shenoy. Anxiolytic effect of acute administration of ursolic acid in rats. Research Journal of Pharmaceutical, Biological, and Chemical Sciences 2011; 2(3):431-437.

69.        Gadekar Dayanand H, Jain Sourabh, Malik Jitender K. Evaluation of anxiolytic activity of Boerhaavia diffusa hydroalcoholic extract of leaves in rats. International Research Journal of Pharmacy 2011; 2(10):90-92.

70.        Habibur Rahman P, Murlidharan D, Sivaraman Kartika B, Dipankar Saha. Evaluation of anxiolytic activity of ethanolic extracts from the leaves of Trichosanthes cucumerina L. in mice. Pelagia Research Library, Der Pharmacia sinica 2010; 1(3):86-94.

71.        Pitsikas N, Boultadakis A, Georgiadou G, Tarantilis PA, Sakellaridis N. Effect of the active constituent of Crocus sativus L., crocins, in an animal model of anxiety. Phytomedicine 2008; 15: 1135-1139.

72.        Wei Xiu-Yan, Yang Jing-Yu, Wang Jin-Hui, Wu Chun-Fu. Anxiolytic effect of saponins from Panax quinquefolium in mice. Journal of Ethnopharmacology 2007; 111: 613-618.

73.        Wijeweera P, Arnason JT, Koszycki D, Merali Z. Evaluation of anxiolytic properties of Gotukola- (Centella asiatica) extracts and asiaticoside in rat behavioral models. Phytomedicine 2006; 13: 668-676.

74.        Rabbani M, Sajjadi SE, Zarei HR. Anxiolytic effect of Stachys lavandulifolia Vahl on the elevated plus maze model in mice. Journal of Ethnopharmacology. 2003; 89: 271-276.

75.        Leite JR, Seabra ML, Maluf E, Assolant K, Suchecki D, Tufik S, Klepacz S. Pharmacology of lemongrass (Cymbopogon citratus Stapf.) III. Assessment of eventual toxic, hypnotic and anxiolytic effects on humans. Journal of Ethnopharmacology 1986; 17: 75–83.

76.        Akhondzadeh S, Naghavi HR, Vazirian M. Passionflower in the treatment of generalized anxiety a pilot double-blind randomized controlled trials with oxazepam. J Clin Pharm Ther 2001; 26: 363–367.

77.        Borner Jon, Andreson LA, Philipson JD. Herbal medicine. 2^nd ed; p.250:253.

78.        Ji Wook Jung, Nam Yoon Ahn, Hye Rim Oh, Bo Kyung Lee, Kang Jin Lee, Sun Yeou Kim, Jae Hoon Cheong, Jong Hoon Ryu. Anxiolytic effects of the aqueous extract of Uncaria rhynchophylla. Journal of Ethnopharmacology 2006; 108: 193 197.

79.        Vandenbogaerde A, Zanoli P, Puia G, Truzzi C, Kamuhabwa A, De Witte P, Merlevede W, Baraldi M. Evidence That Total Extract of Hypericum perforatum Affects Exploratory Behavior and Exerts Anxiolytic Effects in Rats. Pharmacology Biochemistry and Behavior 2000; 65(4): 627–633.

80.        Masoumeh Emamghoreishi, Mohammad Khasaki, Maryam Fath Aazam. Coriandrum sativum Evaluation of its anxiolytic effect in the elevated plus-maze. Journal of Ethnopharmacology 2005; 96: 365–370.

81.        Helli On-Ibarrola MC, Ibarrola DA, Montalbetti Y, Kennedy ML, Heinichen O, Campuzano M, Tortoriello J, Fern andez S, Wasowski C, Marder M, De Limad TCM, Mora S. The anxiolytic-like effects of Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) in mice. Journal of Ethnopharmacology 2006; 105: 400–408.

82.        Oliver Grundmanna, Jun-IchiroNakajimab, KazuakiKamatab, ShujiroSeob, Veronika Butterweck. Kaempferol fromtheleaves of Apocynum venetum possesses anxiolytic activities in the elevated plus maze test in mice. Phytomedicine 2009; 16: 295–302.

83.        Maribel Herrera-Ruiz, Ruben Roman-Ramos, Alejandro Zamilpa, Jaime Tortoriello, Enrique Jimenez-Ferrer J. Flavonoids from Tilia americana with anxiolytic activity in plus-maze test. Journal of Ethno pharmacology 2008; 118: 312–317.

84.        Fabiana Cardoso Vilela, Roseli Soncini, Alexandre Giusti-Paiva. Anxiolytic-like effect of Sonchus oleraceus L. in mice. Journal of Ethno pharmacology 2009; 124: 325–327.

85.        Thongsaard W, Deachapunya C, Pongsakorn S, Boyd EA, Bennett GW, Marsden CA. A Potential Anxiolytic Extracted From Cassia siamea. Pharmacology Biochemistry and Behavior 1996; 53(3): 753-758.

86.        Hongwei Li, Peng Zhou, Qiqi Yang, Yan Shen, Jun Deng Li, De Zhao. Comparative studies on anxiolytic activities and flavonoid compositions of Passiflora edulis ‘edulis’ and Passiflora edulis ‘flavicarpa. Journal of Ethnopharmacology 2011; 133: 1085–1090.

87.        Khalid Saifuddin, Kature Dattatraya, Suresh DK, Shaikh KB, Gopalakrishna CH, Loya PJ. An anxiolytic effect of Dolichandrone falcata leaves extract in experimental animals. RJPBCS 2010; 1(3):524.

88.        Altaf Ali, Venkat Rao N, Md. Shalam, Shivaraj Gouda T, Jeevan Mane Babu, Shantakumar SM. Anxiolytic Activity of Seed Extract of Caesalpinia Bonducella (Roxb) In Laboratory Animals. The Internet Journal of Pharmacology 2008; 5: 2.

89.        Ayoka AO, Akomolafe RO, Iwalewa EO and Ukponmwan. Studies on the anxiolytic effect of Spondias mombin L. (Anacardiaceae) extracts. Afr. J. Trad. CAM 2005; 2(2):153-156.

90.        Shah Gagan, Shri Richa, Mann Avninder. Rahar Sandeep, Panchal Vivek. Anxiolytic effects of Eleacarpus sphaericus fruits on elevated plus maze model of anxiety in mice. International Journal of PharmTech Research 2010; 2(3):1781-1786.

91.        Chandana C Barua, Jayanti D Roy, Bhaben Buragohain, Achinta G Barua, Prabodh Borah, Mangala Lahkar. Anxiolytic effect of hydroethanolic extract of Drymaria cordata L. Willd. Indian Journal of Experimental Biology 2009;47:969-973.

92.        Richa Shri, Manjeet Singh, Anupam Sharma. Bioactivity-directed separation of an anxiolytic fraction from Aethusa cynapium L Journal of Pharmacognosy and Phytotherapy 2010;2(2):17-23.

93.        Avijit Chakraborty, Amudha P, Geetha M, Srjit Singh N. Evaluation of anxiolytic activity of methanolic extract of Sapindus mukorossi Gaertn in mice. International Journal of Pharma and Bio Sciences 2010; 1(3):1-8.

94.        Akindele AJ, Adeyemi OO. Anxiolytic and sedative effects of Byrsocapus coccineus Schum Thonn. (Connaraceae) extract. International Journal of Applied Research in Natural Products 2010; 3(1):28-36.

95.        Reecha Mdaan, Anupam Sharma. Evaluation of anti-anxiety activity of Actaea spicata Linn. International Journal of Pharmaceutical Sciences and research 2011; 3(1):45-47.

96.        Kaplan HI and Sadock BJ. Synopsis of psychiatry. Baltimore: 8^th ed. Williams and Wilkins. 1998. p.591.

97.        American Psychiatric Association. Diagnostic and statistical manual for mental disorders 4^thedition, text revision. DC American Psychiatric Association, Washington; 2000.

98.        Anderson JC, Williams S, McGee R, and Silva PA. DSM-III disorders in preadolescent children: Prevalence in a large sample from the general population. Archives of General Psychiatry 1987; 44: 69−76.

99.        Chavira DA, Stein MB, Bailey K, and Stein MT. Child anxiety in primary care: Prevalent but untreated. Depression and Anxiety 2004; 20: 155−164.

100.          Verduin TL, Kendall PC. Differential occurrence of comorbidity within childhood anxiety disorders. Journal of Clinical Child and Adolescent Psychology 2003; 32: 290−295.

101.          Douglass HM, Moffit TE, Dar R, McGee R. Obsessive compulsive disorder in a birth cohort of 18 year olds: Prevalence and predictors. Journal of the American Academy of Child and Adolescent Psychiatry 1995; 34: 1424−1431.

102.          Kovacs M, Devlin B. Internalizing disorders in childhood. Journal of Clinical Psychology and Psychiatry 1998; 39: 47−63.

103.          Anderson JC, Ollendick TH, King NJ, Yule W. Epidemiological issues. International handbook of phobic and anxiety disorders in children.                         New York: Plenum. 1994. p. 332-345.

104.          Weems CF, Stickle TR. Anxiety disorders in childhood: Casting a nomological net. Clinical Child and Family Psychology Review 2005; 8: 107−134.

105.          Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. American Journal of Psychiatry 2001; 158: 1568−1578.

106.          National Institute of Mental Health. (1999, August) publicat/anxresfact.cfm (NIH Publication No. 99-4504). Anxiety disorders research at the National Institute of Mental Health. Retrieved August 3, 2006. Available from: http://www.nimh.nih.gov/

107.          Rauch SL, Shin LM, and Wright CI. Neuroimaging studies of amygdala function in anxiety disorders. Annals of the New York Academy of Sciences,                    2003; 985: p.389−410.

108.          Millan MJ. The neurobiology and control of anxious states. Progress in Neurobiology 2003; 70: p.83−244.

109.          Wolpe J. Psychotherapy by reciprocal inhibition. Stanford, CA: Stanford University Press 1958.

110.          Mowrer OH. On the dual nature of learning: A re-interpretation of “conditioning” and “problem-solving”. Progress in Neurobiology 1947; 42: p.3−32.

111.          Rachman S. Fear of contamination behaviour. Research and Therapy                    2004; 42: 1227−1255.

112.          Murachver T, Pipe ME, Gordon R, Owens JL, Fivush R. Do show and tell Children's event memories acquired through direct experience, observation, and stories. Child Development 1996; 67: p.3029−3044.

113.          Elizabeth J, King N, Ollendick TH, Gullone E, Tonge B, Watson S. Social anxiety disorder in children and youth: A research update on aetiological factors. Counselling Psychology Quarterly. 2006; 19: 151−163.

114.          Muris P, Steerneman P, Merckelbach H, and Meesters C. The role of parental fearfulness and modeling in children's fear. Behaviour Research and Therapy 1996; 34: 265−268.

115.          Masi G, Favilla L, Mucci M, Millepiedi S. Panic disorder in clinically-referred children and adolescents. Child Psychiatry and Human Development 2000; 31: 139−151.

116.          Francis G, Last CG, Strauss CC. Expression of separation anxiety disorder: The roles of age and gender. Child Psychiatry and Human Development 1987; 18: 82−89.

117.          Ollendick TH. Panic disorder in children and adolescents: New developments, new directions. Journal of Clinical Child Psychology 1998; 27: 234−245.

118.          Diler RS, Birmaher B, Brent DA, Axelson DA, Firinciogullari S, Chiapetta L. Phenomenology of panic disorder in youth. Depression and Anxiety 2004; 20: 39−43.

119.          Kashdan TB, Herbet JD. Social anxiety disorder in childhood and adolescence: Current status and future directions. Clinical Child and Family Psychology Review 2001; 4: 37−61.

120.          Kronenberger WG, Meyer RG. The child clinician's handbook, 2^nd ed. Needham Heights, MA: Allyn and Bacon; 2001.

121.          Masi G, Mucci M, Nicoletta B, Bertini N, Milantoni L, and Arcangeli FA. Naturalistic study of referred children and adolescents with obsessive–compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2005; 41: 1431−1438.

122.          Snider LA, Swedo SE. Paediatric obsessive– compulsive disorder. Journal of the American Medical Association 2000; 284: 3104−3106.

123.          Freeman JB, Garcia AM, Fucci C, Karitani M, Miller L, Leonard HL. Family-based treatment of early-onset obsessive–compulsive disorder. Journal of Child and Adolescent Psychopharmacology 2003; 13 (1), S 71−S80.

124.          Yule W. Post-traumatic stress disorder in children and adolescents. International Review of Psychiatry 2001; 13: 194−200.

125.          Taghavi MR, Dalgleish T, Moradi AR, Neshat-Doost HT, Yule W. Selective  processing of negative emotional information in children and adolescents with generalized anxiety disorder. British Journal of Clinical Psychology                     2003; 42: 221−230.

126.          Kendall PC, and Pimentel SS. On the physiological symptom constellation in youth with generalized anxiety disorder (GAD). Journal of Anxiety Disorders 2003; 17: 211−221.

127.          Beck AT. Cognitive therapy and the emotional disorders. International University Press; New York 1976.

128.          Hoehn-Saric R, McLeod DR. Anxiety and arousal: Physiological changes and their perception. Journal of Affective Disorders 2000; 61: 217−224.

129.          Alfano CA, Ginsburg GS, Kingery JN. Sleep related problems among children and adolescents with anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2007; 46: 224−232.

130.          Storch EA, Merlo LJ. Obsessive–compulsive disorder: Strategies for using CBT and pharmacotherapy. Journal of Family Practice 2006; 55: 329−333.

131.          Sally Roach. Introductory Clinical Pharmacology, 7^th edition.

132.          Fuchs E, Flugge G. Experimental animal models for the simulation of depression and anxiety. Dialogues Clin Neurosci 2006; 8:323-33.

133.          Vogel GH. Drug Discovery and Evaluation Pharmacological Assays 2^nd revised updated and Enlarged Edition. Springer-Verlag Berlin Heidelberg 2002.

134.          Shekhar A, McCann UD, Meany MJ. Summary of a National institute of mental Health workshop: Developing animal models of anxiety disorders. Psychopharmacology 2001; 157:327-39.

135.          Goa KL, Ward A. Buspirone: a preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic drug Indian Journal of Pharmacology 1986; 32:114-29.

136.          Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987; 92:180-185.

137.          Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther 1995; 65:319-95.

138.          Rodgers RJ, Cao BJ, Dalvi A, et al. Animal models of anxiety: an ethological perspective. Braz J Med Biol Res 1997; 30:289-304.

139.          Weiss SM, Lightowler S, Stanhope KJ, Kennett GA, Dourish CT. Measurement of anxiety in transgenic mice. Rev Neurosci 2000; 11:59-74.

140.          Hogg S. A review of the validity and variability of the elevated plus - maze as an animal model of anxiety. Pharmacol Biochem Behav 1996; 54:21-30.

141.          Rodger RJ, Johnson NJT. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 1995; 52:297-303.

142.          Kulkarni SK, Singh K, Bishnoi M. Elevated zero maze: A paradigm to evaluate anti anxiety effects of Drugs. Methods Find Exp Clin Pharmacol 2007; 29:343-8.

143.          Kelley AE. Locomotor activity and exploration. In Sahgal A, Behavioural Neuroscience. A Practical Approach. Vol II. Oxford, UK: IRL Press; 1993: p.1-21.

144.          File SE. Animal models for predicting clinical efficacy of anxiolytic: social behavior. Neuropsychobiol 1985; 13:55-62.

145.          Davis M. The role of the amygdale in fear-potentiated startle: implications for animal models of anxiety. Trends Pharmacol Sci 1992; 13:35-41.

146.          Davis M, Falls WA, Campeau S, Kim M. Fear-potentiated startle: a neural and pharmacological analysis. Behav Brain Res 1993; 58:175-98.

147.          Blanchard RJ, Blanchard DC. Affect and aggression: an animal model applied to human behavior. In: Blanchard RJ, Blanchard DC, eds. Advances in the Study of Aggression. Orlando, Fla: Academic Press Inc; 1984: p.1-62.

148.          Griebel G, Blanchard DC, Jung A, Blanchard RJ. A model of ant predator defense in Swiss-Webster mice: effects of benzodiazepine receptor ligands with different intrinsic activities. Behav Pharmacol 1995; 6:732-745.

149.          Blanchard DC, Griebel G, Blanchard RJ. Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic. Neurosci Biobehav Rev 2001; 25:205-281.

150.          File SE, Gonzalez LE, and Andrews N. Comparative study of pre and postsynaptic 5-HT_1A receptor modulation of anxiety in two ethological animal tests. J Neurosci 1996; 16:4810-4815.

151.          Ramboz S, Oosting R, and Amara DA. Serotonin receptor 5HT-1_A knockout: an animal model of anxiety related disorder. Proc Natl Acad Sci 1998; 95:14476-14481.

152.          Stenzel-Poore MP, Duncan JE, Rittenberg MB. CFR overproduction in transgenic mice: behavioral and immune system modulation. Ann NY Acad Sci 1996; 780:36-48.

153.          Crestani F, Lorez M, Baer K. Decreased GABA-A receptor clustering results in enhanced anxiety and a bias for threat cues. Nat Neurosci 1999; 2:8339.

154.          Finn DA, Rutledge-Gormann MT, Crabbe JC. Genetic animal models of anxiety. Neurogenetics 2003; 4:109-135.

155.          Belzung C, Griebel G. Measuring normal and pathological anxiety- like behavior in mice: a review. Behav Brain Res 2001; 125:141-142.

156.          Broadhurst PL. The maudsley reactive and non-reactive strains of rats: a survey. Behave Genet 1975; 5:299-319.

157.          Goto SH, Conceicao IM, Ribeiro RA, Frussa Filho R. Comparison of anxiety measured in the elevated plus maze, open arms and social interaction tests between spontaneously hypertensive rats and Wistar EPM-1 rats. Braz J Med Biol Res 1993; 26:965-969.

158.          Chaouloff F, Castanon N, Mormede P. Paradoxical differences in animal models of anxiety among the roman rat lines. Neurosci Lett 1994; 182:217-221.

159.          Colombo G, Agabio R, Lobina C. Sardinian alcohol-preferring rats a genetic animal model of anxiety. Physiol Behav 1995; 57:1181-1185.

160.          Liebsch G, Montowski A, Holsboer F. behavioral profiles of two Wistar lines selectively bred for high or low anxiety-related behavior. Behave Brain Res 1998; 94:301-310.

161.          Harborne JB. Phytochemical methods, a guide to modern techniques of plant analysis.3^rd edition. Chapmam & Hall Publicatio; London (UK) 1998: p.06.

162.          Kokate CK, Purohit AP, Gokhale SB.  Pharmacognosy. 24th ed.  Nirali Prakashan Pune; 2003. p.149-153.

163.          Harborne JB. Phytochemical methods, a guide to modern techniques of plant analysis.3^rd edition.; Springer (India) Private Limited New Delhi 1998: p.09.

164.          Kokate CK, Practical Pharmacognosy, 4th Ed (Reprint) Vallabh Prakashan; Delhi 1996:107-111.

165.          Khandelwal KR. Practical Pharmacognosy techniques and experiments. 2^nd edition Pune, Nirali Prakashan 2000; p.149-156.

166.          OECD/OCDE  guidelines 425 for testing of chemicals, acute oral toxicity up-and-down- procedure(UDP) along with the conventional LD50 test and the fixed dose procedure (FDP), OECD test guidelines 420 and 423. Adopted 3^rd October 2008; Available from: http://www.oecd.org

167.          Hogg SA. Review of the validity and Variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 1996; 54: 21-30.

168.          Pellow S, File SE. Anxiolytic and axiogenic drug effects on exploratory activity in an elevated plus-maze a novel test of anxiety in the rat. Pharmacol Biochem Behav 1986; 24: 525-529.

169.          Kulkarni SK. Handbook of Experimental pharmacology. 3^rd edition.New Delhi; Vallabha Prakashan 1999: p.135.

170.          Rodgers RJ, Johnson NJT. Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice. Pharmacol Biochem Behav 1998; 59: 221-232.      

171.          Soman I, Mengi SA, Kasture SB. Effects of leaves of Butuea frondosa on stress, anxiety and cognition in rats. J Pharmacol Biochem Behav 2004; 79:11-16.

172.          Zanoli P, Avallone R, Baraldi M. Behavioral characterization of the flavonoids apigenin and chrysin. Fitoterapia 2000; 71: S117-S123.

173.          Maribel HR. Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans. J Ethnopharmacol 2006; 107: 53-58.

174.          Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 1980; 13: 167-170.

175.          Bhatacharya SK, Satyan KS. Experimental methods for evaluation of psychotropic agents in rodents: anti anxiety agents. Indian J Exp Biol 1997;35:575.

176.          Hellion-Ibarrola MC, Ibarrola DA, Montalbetti Y, Kennedy ML, Heinichen O, Campuzanoa M, Tortoriello J, Fernandez S, Wasowski C, Marder M, De Limad TCM, Mora S. The anxiolytic-like effects of Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) in mice. Journal of Ethnopharmacology 2006; 105: 400–408.

177.          File SE, Seth P. A review of 25 years of the social interaction test. European Journal of Pharmacology 2003; 463: 35-53.